当前位置:首页 - 行情中心 - 南华生物(000504) - 财务分析 - 现金流量表

南华生物

(000504)

  

流通市值:40.88亿  总市值:40.99亿
流通股本:3.29亿   总股本:3.30亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金435,084,003.16107,916,577.56277,578,602.2129,067,161.46
  收到的税费返还2,294,539.582,294,539.583,190,5101,154,692.19
  收到其他与经营活动有关的现金61,626,332.8524,821,058.3919,303,835.217,412,630.73
  经营活动现金流入小计499,004,875.59135,032,175.53300,072,947.41137,634,484.38
  购买商品、接受劳务支付的现金388,248,850.45179,775,628.05313,648,673.7732,055,958.35
  支付给职工以及为职工支付的现金23,107,823.2511,633,148.7358,498,525.6545,541,330.04
  支付的各项税费31,968,478.7420,592,525.9423,669,544.1111,243,358.51
  支付其他与经营活动有关的现金61,639,610.2913,732,689.3319,991,551.3931,468,952.54
  经营活动现金流出小计504,964,762.73225,733,992.05415,808,294.92120,309,599.44
  经营活动产生的现金流量净额-5,959,887.14-90,701,816.52-115,735,347.5117,324,884.94
二、投资活动产生的现金流量:
  收回投资收到的现金888,000,000336,000,000278,000,000105,000,000
  取得投资收益收到的现金1,793,159.32577,580.394,080,006.715,328,704.21
  处置固定资产、无形资产和其他长期资产收回的现金净额24,601.87-17,50017,500
  投资活动现金流入小计889,817,761.19336,577,580.39282,097,506.71110,346,204.21
  购建固定资产、无形资产和其他长期资产支付的现金5,843,564.512,792,5585,119,160.3813,823.2
  投资支付的现金888,000,000456,000,000178,000,000105,000,000
  取得子公司及其他营业单位支付的现金2,431,245-61,231,129.8961,225,585.03
  支付其他与投资活动有关的现金--10,861,942.68-
  投资活动现金流出小计896,274,809.51458,792,558255,212,232.87167,039,408.23
  投资活动产生的现金流量净额-6,457,048.32-122,214,977.6126,885,273.84-56,693,204.02
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,250,0001,250,000
  其中:子公司吸收少数股东投资收到的现金--1,250,000-
  取得借款收到的现金10,000,000-22,300,000-
  收到其他与筹资活动有关的现金76,750,00056,123,571.2246,711,744.13-
  筹资活动现金流入小计86,750,00056,123,571.2270,261,744.131,250,000
  偿还债务支付的现金16,010,0005,000,00033,515,0001,000,000
  分配股利、利润或偿付利息支付的现金1,902,805.16979,946.973,927,652.332,034,725.32
  其中:子公司支付给少数股东的股利、利润--1,562,500-
  支付其他与筹资活动有关的现金94,219,717.8617,4424,537,078.653,559,542.44
  筹资活动现金流出小计112,132,522.966,597,388.9741,979,730.986,594,267.76
  筹资活动产生的现金流量净额-25,382,522.9649,526,182.23228,282,013.15-5,344,267.76
四、汇率变动对现金及现金等价物的影响-83.67--61.29-11.45
五、现金及现金等价物净增加额-37,799,542.09-163,390,611.9139,431,878.19-44,712,598.29
  加:期初现金及现金等价物余额346,765,025.12346,765,025.12207,333,146.93207,333,146.93
  期末现金及现金等价物余额308,965,483.03183,374,413.22346,765,025.12162,620,548.64
补充资料:
  净利润865,013.31-18,052,280.09-
  资产减值准备4,120,591.21-16,824,469.79-
  固定资产和投资性房地产折旧4,955,936.85-4,146,729.48-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧4,955,936.85-4,146,729.48-
  无形资产摊销1,656,075.33-438,547.29-
  长期待摊费用摊销2,041,684.01-23,942,583.96-
  处置固定资产、无形资产和其他长期资产的损失713.47--4,854.13-
  固定资产报废损失--22,914.29-
  公允价值变动损失--165,128-
  财务费用4,334,148.99-2,587,541.91-
  投资损失-1,524,115.62--7,874,289.7-
  递延所得税-3,763,041.68--910,675.92-
  其中:递延所得税资产减少-3,437,907.55--1,020,953.25-
    递延所得税负债增加-325,134.13-110,277.33-
  存货的减少-34,900,102.85-2,580,818.51-
  经营性应收项目的减少110,471,224.58--173,673,633.53-
  经营性应付项目的增加-95,333,591.74--4,859,296.74-
  现金的期末余额308,965,483.03-346,765,025.12-
  减:现金的期初余额346,765,025.12-207,333,146.93-
  现金及现金等价物的净增加额-37,799,542.09-139,431,878.19-
公告日期2026-08-242026-04-292026-04-292025-10-27
审计意见(境内)标准无保留意见
TOP↑